Quantcast
Last updated on April 21, 2014 at 7:52 EDT

Latest Quigley Pharma Inc. Stories

2009-12-03 15:38:00

DOYLESTOWN, Pa., Dec. 3 /PRNewswire-FirstCall/ -- Ted Karkus, Chairman and CEO of The Quigley Corporation, (Nasdaq: QGLY) www.quigleyco.com announced today that the Company has completed its evaluation of its opportunities to develop prescription pharmaceutical and OTC products and has concluded that it is in its best interests to focus primarily on the OTC/Personal Care marketplace, which may include but are not limited to its Cold-EEZE® and Kids-EEZE®...

2009-11-12 07:30:00

DOYLESTOWN, Pa., Nov. 12 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY) www.quigleyco.com today reported net sales of $5.0 million for the three months ended September 30, 2009, compared to net sales of $6.4 million for the three months ended September 30, 2008. The Company generated net income for the three months ended September 30, 2009, of $1.2 million, or $0.09 per share, compared to net income of $879,000, or $0.07 per share, for the three months ended September...

2009-11-11 06:00:00

DOYLESTOWN, Pa., Nov. 11 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY), www.quigleyco.com today announced it will host a conference call in which Ted Karkus, Chairman and CEO, will provide a Company overview including a review of activities, third quarter results and Q&A. The conference call will be web cast live on The Quigley Corporation's web site, (www.quigleyco.com), at 11:00 AM (ET) on Thursday, November 12, 2009. The Company will issue its third quarter...

2009-11-06 06:00:00

DOYLESTOWN, Pa., Nov. 6 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY), www.quigleyco.com, today announced it will issue its third quarter results at 8:30 AM (ET) on Thursday, November 12, 2009. Ted Karkus, Chairman and CEO, will provide a Company overview, including a review of activities and third quarter results, on a conference call which will be web cast live on The Quigley Corporation's web site, (www.quigleyco.com), at 11:00 AM (ET) that morning. A replay of the...

2009-08-18 13:02:00

DOYLESTOWN, Pa., Aug. 18 /PRNewswire-FirstCall/ -- The Quigley Corporation "The Company" (Nasdaq: QGLY), www.quigleyco.com, today announced that its Board of Directors has approved updating and amending its By-laws and Rights Agreement. The By-laws of the Company were amended and restated to reflect accepted best practices, including updates with respect to Nevada corporate law and to provide advance notice procedures for stockholder nominations for directors and stockholder proposals....

2009-08-05 15:30:00

DOYLESTOWN, Pa., Aug. 5 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY), www.quigleyco.com announced that a replay of its second quarter results conference call audio web cast is available in its entirely on its web site, (www.quigleyco.com). The web cast included a broad discussion on the current status of the Company by Ted Karkus, Chairman and CEO, including a review of recent activities and plans for both its OTC and Pharma operations. The Company is aware that some...

2009-08-05 06:00:00

DOYLESTOWN, Pa., Aug. 5 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY) www.quigleyco.com today reported net sales of $1.7 million for the second quarter ended June 30, 2009, compared to net sales of $2.1 million for the second quarter ended June 30, 2008. The net loss for the second quarter ended June 30, 2009 was $4.6 million, or ($0.36) per share, compared to a net loss of $2.9 million, or ($0.22) per share for the second quarter ended June 30, 2008. The net loss...

2009-07-30 06:00:00

DOYLESTOWN, Pa., July 30 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY), www.quigleyco.com today announced it will issue its second quarter results before market open on Wednesday, August 5, 2009. Ted Karkus, Chairman and CEO, will provide a Company overview including a review of recent activities and second quarter results on a conference call which will be web cast on The Quigley Corporation's web site, (www.quigleyco.com), at 10:00 AM (ET) that morning. A replay...

2009-07-22 07:09:00

DOYLESTOWN, Pa., July 22 /PRNewswire-FirstCall/ -- Quigley Pharma Inc., a wholly-owned subsidiary of The Quigley Corporation (Nasdaq: QGLY) www.quigleyco.com, today announced the results from its Phase IIb double-blind, placebo-controlled, study of topical compound QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. The study was completed with fewer than expected evaluable patients with the final and comprehensive conclusions revealing that (i) the compound is safe and...

2009-07-17 07:39:00

DOYLESTOWN, Pa., July 17 /PRNewswire-FirstCall/ -- The Quigley Corporation, (Nasdaq: QGLY), www.quigleyco.com, today announced that Ted Karkus, Chairman of the Board of The Quigley Corporation, has been appointed Chief Executive Officer by the Board of Directors of the Company. The Company also announced today that Robert V. Cuddihy, Jr. has been appointed Chief Operating Officer. Ted Karkus recently conducted a successful proxy contest which resulted in his slate of directors being...